Company
Nanosonics Limited
Headquarters: Lane Cove, NSW, Australia
Employees: 339
CEO: Mr. Michael C. Kavanagh BSc, M.B.A.
Market Cap
A$1.31 Billion
AUD as of Jan. 1, 2024
US$891.0 Million
Nanosonics Limited Categories
Australia Healthcare Medical Instruments & SuppliesAustralia Healthcare Australia Medical Instruments & Supplies
Top Competitors by Market Capitalization
Industry: Medical Instruments & Supplies
| Company | Market Cap (USD) |
|---|---|
| Intuitive Surgical, Inc. | $113.81 B |
| EssilorLuxottica SA | $90.57 B |
| Becton, Dickinson and Company | $70.33 B |
| HOYA Corp | $43.39 B |
| Alcon Inc. | $37.65 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. The company offers its products primarily to sonographers, hospitals, obstetricians, and gynecologists. Nanosonics Limited was incorporated in 2000 and is headquartered in Lane Cove, Australia.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Nanosonics Limited has the following listings and related stock indices.
Stock: ASX: NAN wb_incandescent